CVS Health Corporation (CVS)
NYSE · Healthcare · Healthcare Plans
$87.01+0.64%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $111B
- P/E (trailing)
- 22.9
- Forward P/E
- 10.2
- Dividend yield
- 3.1%
- 52-week range
- $69.51 – $110.68
- 52-week change
- +12.11%
- EPS (trailing)
- $3.80
- Analyst rating
- 1.4 Strong buy
- Next earnings
- Nov 4, 2026
Fiscal year to Dec 2025
- Revenue
- $402B (+7.85%)
- Net income
- $1.8B
- Operating margin
- 1.2%
- Diluted EPS
- $1.39
- Free cash flow
- $7.8B
From the company’s annual report on SEC EDGAR.
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans.
Headquarters: Woonsocket, United States · 219,000 employees · cvshealth.com